Cloud-based managed-market of goods & services for prescription industry. Reduces med costs, saves lives & enhances healthcare informatics
60% of US prescriptions ("Rxs") are sold at brick-and-mortar pharmacies, with 2010 sales of $182B (3.73B Rxs). The production of Rxs is siloed and wasteful; at pharmacies, at distributors and at manufacturers. Medicare mandate and patent expiries reduce margins and emphasize urgency for change. Rexanto managed-market for Rx industry saves $16B in $98B sector. UPS Healthcare, 7 manufacturers and network of 90 pharmacies have signed on.